Failing CJ, Boehnke KF, Riebschleger M, et al. - Among caregivers of children with juvenile idiopathic arthritis (JIA), an infrequent use but a large interest in cannabidiol (CBD) was noted. Since safety of CBD in children with JIA is unknown, better studies and education around CBD for pediatric rheumatologists are required.

• A total of 136 primary caregivers of JIA patients completed surveys regarding their knowledge and attitudes towards CBD.

• Of respondents, 34.5% (n=47) were not interested in using CBD for their child’s JIA, while 54% (n=79) admitted contemplating using CBD and 7% (n=10) reported current use of CBD.

• Of those contemplating or actively using a CBD product, only 2% learned about CBD from their child’s rheumatologist, vs television (70%) or a friend (50%).

• Discussion with the child's rheumatologist about using CBD was absent in most cases.

• Current users of CBD reported mostly using oral or topical products, and only 10% of respondents (n=1) were aware of what dose they were giving their child.